Arbutus Biopharma (ABUS) Price to FCF (2013 - 2026)
Powered by 
Analysis
Arbutus Biopharma (ABUS) Price to FCF (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Arbutus Biopharma | 1.01 Bn | 921.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -157.63 |
| Mar 31, 2026 | -109.28 |
| Dec 31, 2025 | -197.88 |
| Sep 30, 2025 | -149.81 |
| Jun 30, 2025 | -37.60 |
| Mar 31, 2025 | -49.90 |
| Dec 31, 2024 | -59.72 |
| Sep 30, 2024 | -35.17 |
| Jun 30, 2024 | -40.21 |
| Mar 31, 2024 | -23.98 |
| Dec 31, 2023 | -24.56 |
| Sep 30, 2023 | -15.60 |
| Jun 30, 2023 | -18.80 |
| Mar 31, 2023 | -18.25 |
| Dec 31, 2022 | -21.42 |
| Sep 30, 2022 | -15.53 |
| Jun 30, 2022 | -19.67 |
| Mar 31, 2022 | 21.57 |
| Dec 31, 2021 | -21.02 |
| Sep 30, 2021 | -29.46 |